News & Events
New Targeted Therapy Schedule Could Keep Melanoma at Bay
Optimizing the timing of targeted therapies for melanoma reverses tumor growth, and resistance can be mitigated
Parkinson’s Gene Initiates Disease Outside of the Brain
The most common gene mutation associated with Parkinson’s alters cells circulating outside the brain, not within, offering a new understanding of what causes the disease.
Award Helps Advance Gastroesophogeal Cancer Immunotherapy
Sidney Kimmel Cancer Center at Jefferson researcher awarded DeGregorio Foundation Grant
Restoring Lipid Synthesis Could Reduce Lung Fibrosis
Increasing the body’s ability to produce lipids in the lungs after damage can prevent the progression of pulmonary fibrosis in preliminary studies.
Study Reveals Stark Racial Differences in Triple Negative Breast Cancer Transcriptomes
The findings could explain why African American women are more prone to invasive, treatment-resistant breast tumors
Thomas Jefferson University To Establish The First Education And Training Center For Biologics Manufacturing In North America In Partnership With Global Leader NIBRT
The Jefferson Institute for Bioprocessing will prepare engineering students and industry professionals to lead in this emerging field
A Protein Could Make Stem Cell Therapy for Heart Attack Damage More Effective
Replenishing a naturally occurring heart protein could improve stem cell therapy after a heart attack
Researchers One Step Closer to Treating Organ Fibrosis
A novel antibody-based therapy that blocks the excessive formation of collagen clusters is safe and effective in multiple animal models of fibrotic disease
Arts & Humanities in Medical School Promote Empathy & Inoculate Against Burnout
Medical students who spend more time engaging in the arts may also be bolstering the qualities that improve their bedside manner with patients, according to new research from Tulane and Thomas Jefferson universities.
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
Bursting oxygen-filled microbubbles in breast cancer makes tumors three times more sensitive to radiation therapy in preliminary tests with animal models of the disease